Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER_GOV × Finasteride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Prostatic Hyperplasia 1

Interventions

pembrolizumab 9 Drug Therapy 8 Bevacizumab 8 Cyclophosphamide 6 Carboplatin 6 Capecitabine 6 tislelizumab 5 Surgical Procedures, Operative 5 Radiotherapy 5 Paclitaxel 5 Oxaliplatin 5 Nivolumab 5 Docetaxel 5 Immune Checkpoint Inhibitors 4 Gemcitabine 4 Fluorouracil 4 Endoscopic Mucosal Resection 4 Control Groups 4 Cisplatin 4 pegylated granulocyte colony-stimulating factor 3 fludarabine 3 Neoadjuvant Therapy 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Cytarabine 3 sintilimab 2 lenvatinib 2 human papillomavirus vaccine, L1 type 16, 18 2 fludarabine phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06001619 2023-08-21

PROMED

Turku University Hospital

Phase 4 Recruiting

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡